APA (7th ed.) Citation

LS, D., A, L., CW, R., R, F., D, A., JM, D., . . . PS, C. (2013). Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study. Gastroenterology, 145(2), 329. https://doi.org/10.1053/j.gastro.2013.04.006

Chicago Style (17th ed.) Citation

LS, Dove, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, and Covington PS. "Eluxadoline Benefits Patients with Irritable Bowel Syndrome with Diarrhea in a Phase 2 Study." Gastroenterology 145, no. 2 (2013): 329. https://doi.org/10.1053/j.gastro.2013.04.006.

MLA (9th ed.) Citation

LS, Dove, et al. "Eluxadoline Benefits Patients with Irritable Bowel Syndrome with Diarrhea in a Phase 2 Study." Gastroenterology, vol. 145, no. 2, 2013, p. 329, https://doi.org/10.1053/j.gastro.2013.04.006.